|
Dec. 04, 2023 |
|
|
Oct. 21, 2024 |
|
|
jRCT1030230487 |
Relation of leg muscle oxygen availability to leg muscle volume and leg muscle fitness during incremental exercise in patients with heart failure. |
|
Relation of leg muscle oxygen availability to leg muscle volume and leg muscle fitness during incremental exercise in patients with heart failure. |
Kazuya Yoshizawa |
||
St. marianna university school of medicine yokohama city seibu hospital |
||
1197-1 Yasashi-cho, Asahi-ku, Yokohama-shi, Kanagawa 241-0811 JAPAN |
||
+81-45-366-1111 |
||
y-kazuya@marianna-u.ac.jp |
||
Shinji Nemoto |
||
St. marianna university school of medicine |
||
2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan |
||
+81-45-985-6586 |
||
shinji4df@marianna-u.ac.jp |
Recruiting |
Dec. 04, 2023 |
||
| June. 19, 2024 | ||
| 125 | ||
Interventional |
||
non-randomized controlled trial |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
other |
||
Male heart failure patients aged 40 years or older who have been diagnosed with heart failure and are scheduled to undergo cardiopulmonary exercise testing in an outpatient setting will be included in the study. Diagnostic criteria for heart failure will be in accordance with the diagnostic criteria for patients with chronic heart failure in the Guidelines for the Diagnosis and Management of Acute and Chronic Heart Failure (2017 revised edition). The severity of heart failure will be defined as stage C of the AHA/ACC (American Heart Association / American College of Cardiology) stage classification, i.e., symptomatic heart failure. |
||
The following are contraindications to the exercise stress test as outlined by the American College of Sports Medicine. These are: critical myocardial ischemia or acute myocardial infarction (within 2 days of onset), recent nonsignificant resting ECG changes suggestive of other acute cardiac events, unstable angina, symptomatic or poorly controlled arrhythmia resulting in hemodynamic abnormalities, symptomatic severe aortic stenosis, poorly controlled symptomatic heart failure, acute pulmonary embolism or pulmonary infarction, acute myocarditis or pericarditis, dissecting aortic aneurysm or suspected aortic aneurysm, acute pulmonary embolism, or pulmonary infarction. Symptomatic severe aortic valve stenosis, symptomatic uncontrolled heart failure, acute pulmonary embolism or pulmonary infarction, acute myocarditis or pericarditis, dissecting aortic aneurysm or its suspicion, acute infection with fever, body pain and lymph gland swelling. |
||
| 40age old over | ||
| No limit | ||
Male |
||
Heart failure |
||
Measurement of cardiac output, cardiac output, cardiac index, and muscle oxygen saturation during cardiopulmonary exercise testing. |
||
D006333 |
||
Lower extremity muscle oxygen utilization capacity (lower extremity muscle oxygen saturation, arterial-mixed venous oxygen difference) during cardiopulmonary exercise testing. |
||
Difficulties in activities of daily living |
||
| St. marianna university school of medicine |
| Ethics Committee of St. Marianna University School of Medicine | |
| 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511 Japan, Kanagawa | |
+81-44-977-8111 |
|
| Approval | |
Nov. 10, 2023 |
No |
none |